rifampicin
UkraineDrugs containing this active substance
-
The drug is used for the treatment of tuberculosis (initial phase of pulmonary and extrapulmonary processes), specifically in combination with other anti-tuberculosis agents.
Form: tablets, film-coated
Active substance Dosage rifampicin 150 mg pyrazinamide 400 mg ethambutol 275 mg isoniazid 75 mg ATC: J04AM06
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is used for the complex therapy of tuberculosis (various forms), atypical mycobacterioses, as well as for the treatment of other infectious diseases caused by pathogens sensitive to it (e.g., brucellosis, legionellosis, leprosy). It is also used for the prevention of meningococcal meningitis in bacterial carriers.
Form: capsules
Active substance Dosage rifampicin 150 mg ATC: J04AB02
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is used in the complex therapy of tuberculosis (various forms), atypical mycobacterioses, as well as other infectious diseases caused by susceptible pathogens (e.g., brucellosis, legionellosis, leprosy). It is also used for the prevention of meningococcal meningitis in infection carriers.
Form: capsules
Active substance Dosage rifampicin 300 mg ATC: J04AB02
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is used to treat tuberculosis (in all forms), leprosy, brucellosis, Legionnaires' disease, and severe staphylococcal infections. It is prescribed intravenously if the patient cannot take medication orally (e.g., in a coma or after surgery) or has problems with drug absorption in the gastrointestinal tract.
Form: powder, lyophilized for infusion solution
Active substance Dosage rifampicin 600 mg ATC: J04AB02
Manufacturer: Maylan Laboratories Limited - sterile medicinal products division
-
The drug is used to treat tuberculosis (various forms), atypical mycobacterioses, leprosy, legionellosis, brucellosis, and severe staphylococcal infections. It is also used for the prevention of meningococcal meningitis in infection carriers.
Form: capsules
Active substance Dosage rifampicin 150 mg ATC: J04AB02
Manufacturer: PJSC "Scientific and Production Center "Borshchahivskyy Chemical and Pharmaceutical Plant"
-
The drug is used to treat tuberculosis (both in the initial phase of pulmonary or extrapulmonary processes and during the maintenance phase).
Form: tablets, film-coated
Active substance Dosage rifampicin 150 mg isoniazid 75 mg ethambutol 275 mg ATC: J04AM
Manufacturer: Lupin Limited
-
The medicinal product is intended for the treatment of tuberculosis in children weighing less than 25 kg during the continuation phase.
Form: tablets, dispersible
Active substance Dosage rifampicin 75 mg isoniazid 50 mg ATC: J04AM02
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for the initial phase of tuberculosis treatment in children caused by Mycobacterium tuberculosis, in accordance with WHO guidelines.
Form: tablets, dispersible
Active substance Dosage rifampicin 75 mg isoniazid 50 mg pyrazinamide 150 mg ATC: J04AM05
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is used for the treatment of tuberculosis (pulmonary and extrapulmonary) in both the initial and maintenance phases of therapy.
Form: tablets, film-coated
Active substance Dosage rifampicin 150 mg isoniazid 75 mg ATC: J04AM02
Manufacturer: Lupin Limited
-
Rifampicin, isoniazid, pyrazinamide and ethambutol hydrochloride tablets are used for the treatment of pulmonary and extrapulmonary tuberculosis during the intensive (initial) phase of therapy.
Form: tablets, film-coated
Active substance Dosage rifampicin 150 mg isoniazid 75 mg pyrazinamide 400 mg ethambutol 275 mg ATC: J04AM06
Manufacturer: Lupin Limited
-
Rifampicin/isoniazid is used for the treatment of pulmonary tuberculosis and extrapulmonary tuberculosis in both the initial and maintenance phases of therapy.
Form: tablets, film-coated
Active substance Dosage rifampicin 150 mg isoniazid 75 mg ATC: J04AM02
Manufacturer: Macleods Pharmaceuticals Limited